Bone Biologics files patent for novel bone regeneration technology

[Redaktion]

Bone Biologics, a developer of advanced orthobiologic products, has filed a U.S. patent application for its NELL-1 protein technology. This novel approach aims to improve the success rates of spinal fusion surgery and address significant unmet needs in the multi-billion-dollar bone graft market.

https://www.notebookcheck.net/Bone-Biologics-files-patent-for-novel-bone-regeneration-technology.1049417.0.html